The type of response to preoperative therapy during a Colorectal Cancer Care Spell.
Note: This item does not adhere to NHS England Data Design Principles but cannot be changed for this version of the data set as it is included in the Royal College of Pathologists data set only. It should not be used in any other data set until the Data Design Principles are met.
National Codes:
| 1 | No residual Tumour CELLS / mucous lakes only (Retired 1 April 2018) |
| 2 | Minimal residual cancer (Retired 1 April 2018) |
| 3 | No marked regression (Retired 1 April 2018) |
| 4 | No viable Tumour CELLS (fibrosis or mucus lakes only) (Retired 1 April 2020) |
| 5 | Single Tumour CELLS or scattered small groups of cancer CELLS (Retired 1 April 2020) |
| 6 | Residual cancer outgrown by fibrosis (Retired 1 April 2020) |
| 7 | Minimal or no regression (extensive residual Tumour) (Retired 1 April 2020) |
| 08 | No viable cancer CELLS (TRS 0) |
| 09 | Single CELLS or rare small groups of cancer CELLS (TRS 1) |
| 10 | Residual cancer with evident Tumour regression (TRS 2) |
| 11 | No evident Tumour regression (TRS 3) |
This attribute is also known by these names:
| Context | Alias |
|---|---|
| plural | PREOPERATIVE THERAPY RESPONSE TYPES |